EFAI develops AI-powered clinical solutions designed to improve diagnostic consistency and healthcare workflow efficiency. Its portfolio includes AutoSeg for automated radiotherapy organ contouring, AI-based bone-age assessment, AdaptInsight for adaptive radiotherapy evaluation, and other medical imaging and diagnostic-support systems. Several products have obtained regulatory clearances from Taiwan's TFDA and the U.S. FDA.
The company also operates cloud biomedical platforms for genomic analysis, intelligent health-check scheduling and personalized health-management applications. Its business model combines AI algorithms, clinical data, cloud infrastructure and medical-device software to serve hospitals, healthcare institutions, biotechnology companies and health-management providers.

Login/Register
Supplier Login

















